Sensex, Nifty rise on virus vaccine hopes, financials lead gainsSensex, Nifty rise on virus vaccine hopes, financials lead gains
People walk past the Bombay Stock Exchange building in Mumbai

BENGALURU (Reuters) – Indian shares rose in line with Asian peers on Thursday as investors clung on to hopes of a vaccine for COVID-19, while the central bank’s move to improve liquidity at shadow lenders boosted financial stocks.

The Nifty rose 0.73% to 10,506.7 by 0348 GMT, while the Sensex was up 0.71% at 35,666.57.

MSCI’s broadest index of Asia Pacific shares outside of Japan rose 0.9%, following a strong close on Wall Street after a COVID-19 vaccine from Pfizer and Germany’s BioNTech was found to be well tolerated in early-stage human trials.

On Wednesday, the Reserve Bank of India announced a government-backed fund to buy debt from shadow banks, in a move seen easing a liquidity crunch in the sector.

Bajaj Finance Ltd rose as much as 2.1% and was the top gainer on the Nifty 50. The Nifty Bank Index, which has lost more than 30% so far this year, gained 1.3%.

(Reporting by Chris Thomas in Bengaluru; Editing by Rashmi Aich)